Bleeding Disorders in 2035: Michael Makris is Future-Focused at HABIT Summit 2025
Brian O Mahony, CEO of Irish Haemophilia Society, posted in appreciation of Michael Makris on X:
”Professor Michael Makris giving his view on bleeding disorders treatment and comprehensive care in year 2035 at HABIT Summit 2025 in Osaka, Japan.”
While most of us are still figuring out how to schedule next week’s clinic, Professor Michael Makris is already living in 2035.
At the HABIT Summit 2025 held in Osaka, Japan, Professor Makris, a leading voice in hematology, delivered an insightful presentation on the projected state of bleeding disorders care in the year 2035.
With decades of experience in clinical practice and policy, he offered a forward-looking perspective on how treatment, patient management, and comprehensive care models are expected to evolve over the next decade.
Read Hemostasis Today, to not miss out on important in the field of thrombosis and hemostasis.
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy